
This dynamic video from the Winter Conference on Plasma Spectrochemistry reveal 2026 trends in plasma MS, imaging, and clinical analysis.

Sarah Theiner is a Sales Manager at Nu Instruments based out of Bozeman, Montana. Theiner’s research integrates laser ablation inductively coupled plasma–mass spectrometry (LA-ICP-MS), single-cell ICP-MS, and quantitative calibration strategies to address biological and clinical questions. Her research is designed to advance atomic spectroscopy as an effective platform for elemental and imaging-based studies. Theiner is most known for developing high-resolution imaging workflows using LA-ICP-time-of-flight mass spectroscopy (TOFMS) and multi-element analysis techniques for biological and clinical applications. She was Spectroscopy’s 2026 Emerging Leader in Atomic Spectroscopy awardee.

This dynamic video from the Winter Conference on Plasma Spectrochemistry reveal 2026 trends in plasma MS, imaging, and clinical analysis.

In this video segment, Sarah Theiner explains why using LA-ICP-TOF-MS was the ideal technique for this research compared to more conventional methods. She also touches upon how the findings from her study could inform the design of future chemotherapies and combination treatments.

In this video segment, Sarah Theiner dives into the research that she conducted at the University of Vienna, which focused on how chemoresistance affects drug distribution in the tumor microenvironment.

In this video segment, Sarah Theiner of Nu Instruments reflects on winning the Emerging Leader in Atomic Spectroscopy Award, explaining what winning the award means to her.

Spectroscopy
Single-cell analysis is important in biology and medicine, because it takes into account cell heterogeneity and cellular dynamics, which are governed by cellular crosstalk and the vicinity of cells. Thus, it is of utmost importance to obtain not only information about the heterogeneity of a cell population, but also about their spatial arrangement.

January 29th 2026